A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression
Trial details
- Registry ID
- NCT02614547
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study to Evaluate SAGE-547 in Participants With Severe Postpartum DepressionNCT02614547 | SUPN | Phase 2 | Completed | 2016-06-22Actual |
| Evaluate SAGE-547 in Female Participants With Severe Postpartum DepressionNCT02285504 | SUPN | Phase 2 | Completed | 2015-06-05Actual |
| A Study With SAGE-547 for Super-Refractory Status EpilepticusNCT02477618 | SUPN | Phase 3 | Completed | 2017-07-18Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |